“Therapeutic Antibody Half-Life Extension: Engineering Choices and Their Clinical Consequences”. Translational Medicine & Therapeutics Journal 5, no. 1 (July 11, 2026): 74–82. Accessed November 5, 2026. https://inkwise.org/index.php/TMTJ/article/view/124.